Success Story: EB-1A Approved After RFE for a Professor from China in Biomedicine With Our Expert Guidance
Client’s Testimonial:
"I am writing to express my sincere gratitude for your assistance and to let you know that my application has finally been approved—your support has been invaluable throughout this process.”
On February 3rd, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Professor in the Field of Biomedicine (Approval Notice).
General Field: Biomedicine
Position at the Time of Case Filing: Professor
Country of Origin: China
Country of Residence at the Time of Filing: China
Approval Notice Date: February 3rd, 2026
Processing Time: 22 months, 27 days
Case Summary:
North America Immigration Law Group (Chen Immigration Law Associates) secured EB-1A approval for a professor specializing in biomedicine, with particular expertise in utilizing natural plant functional factors for the prevention and treatment of human diseases. USCIS issued a Request for Evidence (RFE) and ultimately approved the case with our assistance.
The client's work focuses on biomedicine based on drug delivery systems, computationally-driven biomedical research, and natural compound therapeutics. The client's research addresses critical national priorities by advancing nanomedicine, precision medicine, and therapeutic development from natural plant sources.
Research Excellence and Expert Validation
The petition was supported by objective validation through publication in the most prestigious journals in the field and 4 recommendation letters from experts. One expert noted in a support letter:
"[Client]’s extraordinary success as a researcher, as evidenced by [Client]’s independent results, record of publication and citation, and associated position as a cutting-edge innovator in biomedicine, is certain to continue."
Evidence of Independent Influence and Peer RecognitionWith a Ph.D. in chemical engineering and technology, the client is a highly qualified advanced degree scientist with extensive research experience. A strong EB-1A case does not rely on one type of proof. It reads as a converging record, with different categories of evidence corroborating the same conclusion: that the beneficiary's work is influencing the field beyond their immediate environment.
In this matter, the client's credentials showed that pattern clearly:
- 138 peer-reviewed journal articles (31 first-authored), 3 peer-reviewed conference articles, and 3 patents (1 first-authored)
- Research cited 1,030 times
- Recognition through 50 peer reviews for distinguished journals
- Major funding from the National Natural Science Foundation of China, National Youth Top-notch Talent Support Program of China, and National Key Research & Development Program of China
The Result
We congratulate the client on this excellent outcome and are honored that our firm could help present a sophisticated biomedicine research record in a clear, compelling format, especially under RFE scrutiny. The client's sustained international acclaim, validated through extensive citation metrics, independent expert endorsement, and recognition as a leading authority in natural plant therapeutics and nanomedicine, demonstrates qualification as an alien of extraordinary ability at the very top of the field.